Atlas Trials

Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis

Clinical trial NCT03478280 · UNKNOWN

Trial details

NCT number
NCT03478280
Sponsor
Aarhus University Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Psoriasis
Start date
2018-09-15
Primary completion
2020-03-15
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.